Winslow Capital Management LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 54.9% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 3,360 shares of the medical equipment provider’s stock after selling 4,090 shares during the quarter. Winslow Capital Management LLC’s holdings in Intuitive Surgical were worth $1,366,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Bank of America Corp DE increased its position in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after acquiring an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of Intuitive Surgical in the second quarter worth about $1,335,753,000. Amundi raised its stake in shares of Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after acquiring an additional 193,096 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Intuitive Surgical by 10.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock worth $769,948,000 after purchasing an additional 184,044 shares in the last quarter. Finally, Janus Henderson Group PLC lifted its position in shares of Intuitive Surgical by 3.7% during the first quarter. Janus Henderson Group PLC now owns 1,643,060 shares of the medical equipment provider’s stock worth $757,489,000 after purchasing an additional 58,587 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.
More Intuitive Surgical News
These are some of the ISRG news items that stood out recently:
- Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
- Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article
- Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article
Analysts Set New Price Targets
Several analysts have recently commented on ISRG shares. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday, October 21st. TD Cowen restated a “buy” rating and issued a $485.00 price objective on shares of Intuitive Surgical in a research report on Monday, October 19th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Finally, Robert W. Baird increased their price objective on Intuitive Surgical from $513.00 to $550.00 and gave the company an “outperform” rating in a research report on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $495.90.
Get Our Latest Analysis on Intuitive Surgical
Insider Transactions at Intuitive Surgical
In other Intuitive Surgical news, Director Gary Guthart sold 20,095 shares of the firm’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the transaction, the director directly owned 1,204,530 shares of the company’s stock, valued at approximately $543,977,793.30. This trade represents a 1.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $478,416.40. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 39,363 shares of company stock valued at $17,738,749. 0.60% of the stock is currently owned by company insiders.
Intuitive Surgical Trading Down 2.0%
Intuitive Surgical stock opened at $399.06 on Friday. The company has a market cap of $138.33 billion, a PE ratio of 48.25, a PEG ratio of 2.75 and a beta of 1.45. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The company’s 50-day moving average is $423.51 and its two-hundred day moving average is $427.91.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. Intuitive Surgical’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.40 EPS. Research analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
